AI
ISEE

Analytic Investors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Analytic Investors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-29,172
Closed -$1.52M – 645
2015
Q2 		$1.52M Buy
29,172
+11,518
+65% +$573K 0.02% 313
2015
Q1 		$821K Sell
17,654
-7,173
-29% -$372K 0.01% 390
2014
Q4 		$1.11M Buy
24,827
+17,155
+224% +$720K 0.02% 336
2014
Q3 		$299K Buy
+7,672
New +$301K ﹤0.01% 520

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's ISEE Position: Q3 2015 in Review

Analytic Investors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2015, closing a stake of 29,172 shares — an estimated $1.52M sold.

Analytic Investors first reported a position in ISEE in Q3 2014 and held it in 4 quarters. The position peaked at $1.52M in Q2 2015. 144 funds tracked by Wall St. Rank hold ISEE as of Q3 2015.

  • Analytic Investors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Analytic Investors sold 29,172 IVERIC bio, Inc. Common Stock shares in Q3 2015, an estimated $1.52M.
  • Analytic Investors first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and held it in 4 quarters.
  • Analytic Investors's IVERIC bio, Inc. Common Stock position peaked at $1.52M in Q2 2015.
  • 144 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2015.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.